Navigating Together for a Better Tomorrow
How Quasar Is Responding to COVID-19 and Its Effect On Businesses
As the coronavirus pandemic continues to change the world, we’re all navigating through uncertainty.
At Quasar, we embrace our “philosophy of operational excellence”. This means that even in times of struggle, we have an operational focused effort. While our number one concern is the health and safety of our employees and our community, we are also here to assist you with business continuity, even in these uncertain times.
How We're Helping
Meeting all Q-2 commitments and more.
We are here to support the medical device companies globally who have been affected by the pandemic and thus facing challenges to meet previously set production goals. To ensure we are in a position to to support your production needs, we have EXPANDED Manufacturing Capacity in the following areas:
ISO/FDA Registered Facilities
+30k sqft ISO 7/8 Clean Rooms at our ISO/FDA Registered Facilities in China, Hong Kong, and Thailand.
with additional capacity to support Class II & III devices.
Critical Backorders recovery plan
Commercial and Manufacturing teams at the ready to assist with evaluating and developing a recovery plan for you.
Commercial, Quality and Supply Chain teams at the ready to assist with your supplier qualification and approval process to qualify a second source.
Commercial, Quality and Engineering teams at the ready to assist with validation and transfer plans to support a manufacturing transfer project.
Emergency Action Plans
Quasar can assist with developing an emergency (mitigation) action plan to avoid future disruptions to your supply chain.
Many supply-chain vulnerabilities stem from long lead times and high levels of cyclicity that prevent the maintenance of the right inventory balance. OEM companies must identify and solve supply-chain vulnerabilities and risk exposures by creating effective mitigation and business-continuity plans.
China’s overall economic recovery in part has been attributed to the strong rebound in the manufacturing sector. The medical devices manufacturing sector specifically recorded an astounding 46.4% growth.
Many supply-chain vulnerabilities stem from long lead times and high levels of cyclicity that prevent the maintenance of the... read more
China’s overall economic recovery in part has been attributed to the strong rebound in the manufacturing sector. The medical... read more